山高新能源(01250.HK)獲平安創贏旗下保險私募基金40億人幣首期付款
山高新能源(01250.HK)公布,公司已達成增資協議所有先決條件,並獲40億元人民幣首期付款。
公司指,該項目投資者是由平安資產管理附屬公司平安創贏所發起及設立之保險私募基金,引入平安資產管理成為公司的戰略投資人,有利於形成多元化的股權結構和市場化的公司治理結構,對於進一步提升經營管理水平具有重要意義。
此次合作開啟公司與保險資管機構合作的新篇章,進一步增強財務穩定性及投融資能力,為長期發展提供有力的資金保障。公司以此次合作為契機,提升資信實力,建立多元化融資體系,同時也為進一步優化資產結構、打通直接融資市場建立堅定的基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.